Skip to main content
. 2018 Mar 14;13(3):e0190172. doi: 10.1371/journal.pone.0190172

Table 5. Concordance of the provider-collected cervical HPV DNA specimen to the provider-collected vaginal HPV DNA specimen, and of the self-collected vaginal HPV DNA hybridization assay to the provider-collected vaginal HPV DNA specimen.

 A.   Provider-Collected Cervical HPV DNA (n = 53)+ Sensitivity* Specificity* PPV* NPV* Kappa
Positive Negative Total 95% CI 95% CI 95% CI 95% CI 95% CI
Provider-Collected Vaginal HPV DNA
Positive 6 (11.3%) 0 (0.0%) 6 (11.3%)
Negative 1 (1.9%) 46 (86.8%) 47 (88.7%) 85.71% 100.00% 100.00% 97.87% 91.20%
  Total 7 (13.2%) 46 (86.8%) 53 (100%) 0.42, 1.00 0.92, 1.00 0.54, 1.00 0.89, 1.00 0.74, 1.00
 B.   Provider-Collected Vaginal DNA (n = 54)++ Sensitivity* Specificity* PPV* NPV* Kappa
Positive Negative Total 95% CI 95% CI 95% CI 95% CI 95% CI
Self-Collected Vaginal DNA
Positive 6 (11.1%) 1 (1.9%) 7 (13.0%) 85.71% 97.87% 85.71% 97.87% 84.59%
Negative 1 (1.9%) 46 (85.2%) 47 (87.0%) 0.42, 1.00 0.89, 1.00 0.42, 1.00 0.94, 1.00 0.61, 1.00
  Total 7 (13.0%) 47 (87.0%) 54 (100%)          

Author Notes

+Out of 57 tests, there were 4 missing results in the cross tabs (4 missing cervical DNA results of which 2 were also missing for the provider vaginal).

++Out of 57 tests, there were 3 missing results in the cross tabs (2 provider-collected vaginal tests, 1 self-collected vaginal test).

* McNemar’s test used due to the dependency of the data. 95% CI based on exact distribution due to small sample size.